Getinge introduces Advanta V12 balloon expandable covered stent in larger size
For more than 15 years, Getinge’s Advanta V12 balloon expandable covered stent has been trusted by physicians for its ease of use and proven, reliable outcomes. Now, the global medtech company adds a larger diameter size to the portfolio to offer customers increased treatment options within vascular procedures.
Getinge’s Advanta V12 stent has been shown to consistently improve patient outcomes by restoring iliac patency, reducing restenosis and re-intervention rates, improving ankle brachial index (ABIs) and sustaining symptom relief. Strong benchmark data demonstrates superior patency over bare metal stents.
“A clear need from our customers has encouraged us to now introduce a larger diameter size of Advanta V12 which expands from 12 to 16 mm,” says Jens Viebke, President Acute Care Therapies at Getinge.
The first in the world implantation of the Advanta V12 Large Diameter Stent, was performed by Mr. Franklin Pond, a vascular surgeon at the Western Hospital in Melbourne, Australia. Following the procedure, he reported, “I am delighted to expand the treatment spectrum of patients receiving the new Advanta V12 large diameter stent, and pleased with the excellent angiographic outcome.”
Iliac arterial occlusive disease is a peripheral arterial disease (PAD); a condition in which atherosclerosis narrows and blocks peripheral arteries. It develops when narrowing occurs in the iliac arteries, which supply blood to the legs and feet. As the world population ages and rates of diabetes and obesity rise, it is estimated that more and more persons will be affected with iliac artery disease, which puts them at risk for serious complications such as amputation.
“Backed by long-term clinical data and over 500 publications, the Advanta V12 stent continues to prove itself every day when it comes to treating patients with this severe condition. We are of course excited to introduce this new larger size to help our customers treat a wider range of clinical cases,” says Jens Viebke.
A unique full polytetrafluoroethylene (PTFE) encapsulation of the Advanta V12 stent provides a smooth flow lumen and offers an effective barrier to neointimal hyperplasia. It expands uniformly and prevents tissue from prolapsing through the expanded stent. 9F compatibility offers versatility and efficient delivery in complex endovascular procedures.
“The trusted design of Advanta V12 is conformable, deliverable and flexible to track through tortuous arteries and flex to accommodate the iliac arteries. It has the ability to post dilate up to 16mm, providing customization to the patients anatomy,” explains Michel Reijnen, Prof.Dr. at the University of Twente, the Netherlands.
The larger diameter Advanta V12 balloon expandable covered stent is CE marked and TGA approved for restoring and improving the patency of iliac arteries.
Learn more about Advanta V12 >>
This information is intended for an international audience outside of the US.
Media contact:
Anna Appelqvist, Vice President Corporate Communications
Phone: +46 (0)10 335 5906
E-mail: anna.appelqvist@getinge.com
About Getinge
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions that aim to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs over 10,000 people worldwide and the products are sold in more than 135 countries.
